Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications
Advanced Drug Delivery Reviews · 2024-08 · 211 · 115363
DOI: 10.1016/j.addr.2024.115363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-08. Verfasst von Dezhuang Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Washington University in St. Louis, Saint Louis, MO 63130, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Genetic Therapy, Gene Transfer Techniques. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, NINDS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Adeno-associated virus (AAV) vectors have emerged as a promising tool in the development of gene therapies for various neurological diseases, including Alzheimer's disease and Parkinson's disease. However, the blood-brain barrier (BBB) poses a significant challenge to successfully delivering AAV vectors to the brain. Strategies that can overcome the BBB to improve the AAV delivery efficiency to the brain are essential to successful brain-targeted gene therapy. This review provides an overview of existing strategies employed for AAV delivery to the brain, including direct intraparenchymal injection, intra-cerebral spinal fluid injection, intranasal delivery, and intravenous injection of BBB-permeable AAVs. Focused ultrasound has emerged as a promising technology for the noninvasive and spatially targeted delivery of AAV administered by intravenous injection. This review also summarizes each strategy's current preclinical and clinical applications in treating neurological diseases. Moreover, this review includes a detailed discussion of the recent advances in the emerging focused ultrasound-mediated AAV delivery. Understanding the state-of-the-art of these gene delivery approaches is critical for future technology development to fulfill the great promise of AAV in neurological disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Washington University in St. Louis, Saint Louis, MO 63130, USA.
- Department of Biomedical Engineering, Washington University in St. Louis, Saint Louis, MO 63130, USA; Department of Neurosurgery, Washington University School of Medicine, Saint Louis, MO 63110 USA; Mallinckrodt Institu…
Förderung
- NIBIB NIH HHS
- NINDS NIH HHS
- NCI NIH HHS
- NIMH NIH HHS
- Focused Ultrasound Foundation
- National Institutes of Health
Zitieren
APA
Ye, D., Chukwu, C., Yang, Y., Hu, Z., & Chen, H. (2024). Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications. Advanced Drug Delivery Reviews, 211, 115363. https://doi.org/10.1016/j.addr.2024.115363
Vancouver
Ye D, Chukwu C, Yang Y, Hu Z, Chen H. Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications. Advanced Drug Delivery Reviews. 2024;211:115363. doi:10.1016/j.addr.2024.115363
BibTeX
@article{Ye2024,
author = {Ye, Dezhuang and Chukwu, Chinwendu and Yang, Yaoheng and Hu, Zhongtao and Chen, Hong},
title = {Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications},
journal = {Advanced Drug Delivery Reviews},
year = {2024},
volume = {211},
pages = {115363},
doi = {10.1016/j.addr.2024.115363}
}
EUVIMED